Plain-English translation of NCT06905301 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This trial is testing whether a mobile app can help patients with stage II or III hormone-sensitive breast cancer stick with their prescribed medication regimen. The study focuses on , a targeted cancer medication taken alongside hormone therapy. Researchers want to see if reminders and educational information through an app improve how consistently people take their treatment.
Many cancer patients struggle to take their medications exactly as prescribed, which can reduce treatment effectiveness and increase the risk of cancer returning. This study is designed to test whether a mobile app with reminders and educational content can help patients stay committed to this treatment.
You likely qualify if…
You likely don't qualify if…
You will take the medication as your doctor has prescribed. Some participants will also use a mobile application on their phone that sends reminders about taking the medication and provides information about preventing side effects and understanding the importance of staying on treatment. The study follows your treatment in real-world practice, meaning you'll receive care as you normally would while researchers track how consistently you take the medication.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Russia